期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 382, 期 1, 页码 314-324出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.10.022
关键词
Prostate cancer; (R)-bicalutamide; MtDNA; Hormone-resistance; Mitochondrial fission
资金
- Italian Association for Cancer Research (A.I.R.C.) [IG 11520]
- Italian Ministry for University and Scientific Research [2010NFEB9L_002]
Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondria] involvement in the establishment of refractoriness to hormone therapy. Two human prostate cancer cell lines were used, the parental LNCaP and the resistant LNCaPRbic, the latter generated after continuous exposure to 20 RM of (R)-bicalutamide, the active enantiomer of Casodex. We observed a significant decrease in mtDNA content and a lower expression of 8 mitochondria-encoded gene transcripts involved in respiratory chain complexes in both cell lines. We also found that (R)-bicalutamide differentially modulated dynamin-related protein (Drp-1) expression in LNCaP and LNCaP-Rbic cells. These data seem to indicate that the androgen-independent phenotype in our experimental model was due, at least in part, to alterations in mitochondrial dynamics and to a breakdown in the Drp-1-mediated mitochondrial network. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据